{reportSlug=global-ioversol-market, reportId=50350, mktKeyword=Ioversol, cagr=0.00, publishDate=Mar 2024, priceOption2=6800, reportTitle=Ioversol Comprehensive Study by Type (Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240), Ioversol 64% Injectable Solution (Optiray 300), Ioversol 68% Injectable Solution (Optiray 320), Ioversol 74% Injectable Solution (Optiray 350)), Application (X-Ray, CT Scan, Brain Disorders, Blood Vessel Disorders, Heart Disorders, Others) Players and Region - Europe Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3750, forecastYr=2030, noOfPages=170, reportKey=50044, breadcrum=Global Ioversol}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Mar 2024 170 Pages 96 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales